Clark et al(32) have demonstrated previously that TAM, at concentrations of >1 mM, significantly decreased the fluidity of the plasma membrane of ER− breast cancer cells and may have contributed to its non-ER-mediated cytotoxicity. The gene discussed is ESR1; the disease is breast carcinoma.